NOXAFIL (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the NOXAFIL drug offered from Merck Sharp & Dohme Corp.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | posaconazole |
| SUBSTANCE NAME: | POSACONAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-03-13 |
| END MARKETING DATE: | 0000-00-00 |
NOXAFIL HUMAN PRESCRIPTION DRUG Details:
| Item Description | NOXAFIL from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 18(mg/mL) |
| START MARKETING DATE: | 2014-03-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0085-4331_c702df2e-4753-4763-9d05-c22a2cb390c6 |
| PRODUCT NDC: | 0085-4331 |
| APPLICATION NUMBER: | NDA205596 |
Other POSACONAZOLE Pharmaceutical Manufacturers / Labelers:
